SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Swift who wrote (1059)7/31/1998 6:55:00 AM
From: billy d  Read Replies (1) of 10280
 
Heard from a friend of mine who is a broker at Solomon Smith Barney that their analyst up his price target to 80$ for SEPR. Also,his report on the Squawk Box after the conference was extremely bullish.

I do have one concern about a Lilly deal. I read that Lilly was working on a Prozac formulation which consists of a Prozac/anti-schizophrenia drug (whose name escapes me)combo.

Could this throw a monkey wrench into any deal SEPR may cut with them?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News